Vickers Philip J.

CIK 00016350463 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001635046

Recent Transactions

27 trades

Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2026-04-01+214,400→ 214,400 total
Award
Tectonic Therapeutic, Inc.$TECX
Stock Option (Right to Buy)
2023-06-06+17,643→ 17,643 total
Award
Tectonic Therapeutic, Inc.$TECX
Stock Option (Right to Buy)
2022-06-08+17,478→ 17,478 total
Award
Tectonic Therapeutic, Inc.$TECX
Stock Option (Right to Buy)
2022-06-08+17,478→ 17,478 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2022-05-04+11,343→ 11,343 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2022-05-04+10,756→ 10,756 total
Award
Revance Therapeutics, Inc.
Common Stock
2022-05-04+6,059→ 29,722 total
Purchase
Tectonic Therapeutic, Inc.$TECX
Common Stock
2021-07-07$8.35/sh+4,800→ 4,800 total
Award
Tectonic Therapeutic, Inc.$TECX
Stock Option (Right to Buy)
2021-06-10+17,438→ 17,438 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2021-05-05+7,551→ 7,551 total
Award
Revance Therapeutics, Inc.
Common Stock
2021-05-05+4,013→ 23,663 total
Award
Tectonic Therapeutic, Inc.$TECX
Stock Option (Right to Buy)
2020-06-04+14,000→ 14,000 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2020-05-14+12,000→ 12,000 total
Award
Revance Therapeutics, Inc.
Common Stock
2020-05-14+6,000→ 19,650 total
Award
Tectonic Therapeutic, Inc.$TECX
Stock Option (Right to Buy)
2019-06-11+9,675→ 9,675 total
Award
Revance Therapeutics, Inc.
Common Stock
2019-05-09+4,500→ 13,650 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2019-05-09+9,000→ 9,000 total
Award
Tectonic Therapeutic, Inc.$TECX
Stock Option (Right to Buy)
2019-01-07+18,743→ 18,743 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2018-05-10+6,000→ 6,000 total
Award
Revance Therapeutics, Inc.
Common Stock
2018-05-10+3,000→ 9,150 total
Purchase
Revance Therapeutics, Inc.
Common Stock
2018-03-16$31.20/sh+900→ 6,150 total
Purchase
Revance Therapeutics, Inc.
Common Stock
2018-03-16$31.25/sh+2,250→ 5,250 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to Buy)
2017-05-11+6,000→ 6,000 total
Award
Revance Therapeutics, Inc.
Common Stock
2017-05-11+3,000→ 3,000 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to Buy)
2016-05-05+8,000→ 8,000 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to Buy)
2015-05-07+8,000→ 8,000 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to Buy)
2015-02-26+18,000→ 18,000 total

Companies

Recent Filings

Address

C/O AKEBIA THERAPEUTICS, INC 245 FIRST STREET

CAMBRIDGE, MA, 02142

View on SEC.gov